Ironwood Pharmaceuticals (NASDAQ:IRWD) reported its Q4 earnings results on Thursday, February 17, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
Ironwood Pharmaceuticals missed estimated earnings by 22.86%, reporting an EPS of $0.27 versus an estimate of $0.35.
Revenue was up $450.00 thousand from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.02, which was followed by a 2.54% increase in the share price the next day.
Here's a look at Ironwood Pharmaceuticals's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | 0.31 | 0.22 | 0.21 | 0.29 |
| EPS Actual | 0.33 | 0.34 | 0.24 | 0.36 |
| Revenue Estimate | 105.40M | 93.10M | 95.20M | 111.95M |
| Revenue Actual | 103.75M | 104.03M | 88.84M | 116.68M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
